
Atopic Dermatitis & Eczema
The crowd matters.
For far too long, we the people who want to give and get better care have had no say in what new ideas get into practice. When you support new ideas here they are over 20 times more likely to get out to market - sometimes incredibly fast. So explore, like, try, pilot, partner, mentor, or invest in these companies and ideas and let's fix healthcare, one awesome idea at a time!
See the companies ↓Part of Dermatologic Diseases
Sub-areas
Fyggy's top 8 in Atopic Dermatitis & Eczema
Ranked by MedStartr Engagement Score.
- 1
IQVIAMedStartr Engagement Score25MedStartr Engagement Score25 - 2Nia HealthMedStartr Engagement Score7MedStartr Engagement Score7
- 3untickle (アンティクル)MedStartr Engagement Score4MedStartr Engagement Score4
- 3NalaMedStartr Engagement Score4MedStartr Engagement Score4
- 3ItchyMedStartr Engagement Score4MedStartr Engagement Score4
- 3OmhuMedStartr Engagement Score4MedStartr Engagement Score4
- 3Caremind (케어마인드)MedStartr Engagement Score4MedStartr Engagement Score4
- 3Proton HealthMedStartr Engagement Score4MedStartr Engagement Score4
Companies in Atopic Dermatitis & Eczema
Only accessible to MedStartr community members.
Join now
IQVIA
Somerset, New Jersey, United States
IQVIA was formed in 2016 through the acquisition and merger of IMS Health with Quintiles, later rebranded from QuintilesIMS in 2017. It is a global provider of advanced analytic...
...moreOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowOnly accessible to MedStartr community members.
Join nowAtopic Dermatitis & Eczema Salon
Share photos and talk with people who care about Atopic Dermatitis & Eczema. Please follow the community rules.
Sign in to join the conversation.
Sign in to comment
